Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
D000124:Achievement; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001538:Bender-Gestalt Test; D001925:Brain Damage, Chronic / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003071:Cognition / Q000187:drug effects; D003913:Dextroamphetamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage / Q000627:therapeutic use*; D010389:Pemoline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010465:Perception / Q000187:drug effects; D010919:Placebos; D011581:Psychological Tests; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced
D000697:Central Nervous System Stimulants; D010919:Placebos; D008774:Methylphenidate; D010389:Pemoline; D003913:Dextroamphetamine